Search

everythinglearnresearchcommunity

for

Search:↓

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Women over forty can maintain skin and hair health with lifestyle and dietary changes.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Antiepileptic drugs can cause cosmetic side effects and affect menstrual cycles, fertility, and bone health in women with epilepsy.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Iron and zinc deficiencies may be treated to help female hair loss.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

No significant difference in iron deficiency between women with or without hair loss.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.